Abstract
Background: The effect of controlled-onset, extended-release (COER) verapamil on haemodynamic parameters in obese and non-obese patients is evaluated in this analysis.
Methods: Data were pooled from three clinical trials evaluating efficacy and tolerability of COER-verapamil. Hypertensive men and women (stage I to III) were randomised to COER-verapamil (180–540 mg at bedtime) or placebo for 4–8 weeks and stratified according to body mass index (BMI-obese >28 kg/m2). Efficacy was assessed as change from baseline in blood pressure (BP), heart rate, and rate-pressure product during four time periods throughout the dosing interval. Safety and tolerability were assessed by monitoring all adverse events and changes in metabolic laboratory parameters.
Results: Reductions in all haemodynamic parameters were significantly greater following COER-verapamil compared with placebo for all time periods. The haemodynamic effects of COER-verapamil in obese (n= 166, BMI = 32.8 kg/m2) and non-obese patients (n = 115, BMI = 25.0 kg/m2) were similar. COER-verapamil was well tolerated in both subgroups, but the incidence of constipation was significantly less in obese patients (P < 0.001).
Conclusions: COER-verapamil is effective in reducing BP, heart rate, and rate-pressure product independently of BMI.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
This work was presented, in part, at the 100th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, March 18, 1999, in San Antonio, Texas, USA
Rights and permissions
About this article
Cite this article
White, W., Elliott, W., Johnson, M. et al. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hypertens 15, 135–141 (2001). https://doi.org/10.1038/sj.jhh.1001137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001137
- Springer Nature Limited
Keywords
This article is cited by
-
Ambulatory blood pressure monitoring in childhood and adult obesity
Current Hypertension Reports (2009)
-
Treatment strategies for obesity-related hypertension
Current Hypertension Reports (2008)
-
Management of arterial hypertension in obese patients
Current Hypertension Reports (2007)
-
Management of hypertension in overweight and obese patients: A practical guide for clinicians
Current Hypertension Reports (2005)